IRIS
DI SERAFINO, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.998
EU - Europa 2.262
NA - Nord America 1.806
SA - Sud America 461
AF - Africa 90
OC - Oceania 5
Totale 7.622
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.728
SG - Singapore 1.632
RU - Federazione Russa 1.202
CN - Cina 702
IT - Italia 393
BR - Brasile 363
HK - Hong Kong 256
VN - Vietnam 222
NL - Olanda 145
DE - Germania 129
FI - Finlandia 108
UA - Ucraina 54
GB - Regno Unito 52
CA - Canada 47
AR - Argentina 43
FR - Francia 43
IE - Irlanda 35
KR - Corea 31
BD - Bangladesh 30
CI - Costa d'Avorio 26
ZA - Sudafrica 24
IN - India 22
JP - Giappone 18
AT - Austria 17
ID - Indonesia 17
MX - Messico 17
EC - Ecuador 16
PL - Polonia 15
SE - Svezia 12
VE - Venezuela 9
CH - Svizzera 8
CZ - Repubblica Ceca 8
ES - Italia 8
TR - Turchia 8
CO - Colombia 7
IQ - Iraq 7
LT - Lituania 7
MA - Marocco 7
CL - Cile 6
KE - Kenya 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
IL - Israele 5
PK - Pakistan 5
UY - Uruguay 5
BE - Belgio 4
IR - Iran 4
MY - Malesia 4
TN - Tunisia 4
AL - Albania 3
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
UZ - Uzbekistan 3
BN - Brunei Darussalam 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
ME - Montenegro 2
MK - Macedonia 2
MW - Malawi 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
YT - Mayotte 2
AO - Angola 1
AZ - Azerbaigian 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
GA - Gabon 1
GF - Guiana Francese 1
GH - Ghana 1
GN - Guinea 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
NA - Namibia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 7.615
Salva come PNG Salva come JPEG
Città #
Singapore 764
Moscow 304
Hong Kong 256
Beijing 177
Ashburn 172
Hefei 156
Chandler 143
Naples 129
Amsterdam 126
Santa Clara 99
Millbury 78
Ho Chi Minh City 69
Los Angeles 69
Boston 67
Princeton 64
Nanjing 58
Hanoi 53
Munich 53
Redondo Beach 39
Buffalo 37
Des Moines 35
New York 33
Ottawa 29
Seoul 29
São Paulo 27
Wilmington 24
Jacksonville 23
Afragola 18
Lappeenranta 18
Nanchang 18
Turku 17
Dallas 16
Haiphong 16
Helsinki 16
Nuremberg 16
Orem 16
Rio de Janeiro 16
Lawrence 15
Shenyang 14
The Dalles 14
Tianjin 14
Tokyo 14
Denver 13
Jiaxing 13
Seattle 13
Dong Ket 12
Frankfurt am Main 12
Johannesburg 12
Atlanta 11
Hebei 11
Napoli 11
Poplar 11
Warsaw 11
Washington 11
Brasília 10
Belo Horizonte 9
Biên Hòa 9
Chicago 9
Milan 9
Phoenix 9
Porto Alegre 9
Stockholm 9
Augusta 8
Brooklyn 8
Dhaka 8
Montecchio Emilia 8
Montreal 8
Rome 8
San Francisco 8
San Giuseppe Vesuviano 8
Fairfield 7
Norwalk 7
Ribeirão Preto 7
Roubaix 7
Torre del Greco 7
Buenos Aires 6
Council Bluffs 6
Da Nang 6
Guayaquil 6
Nairobi 6
São Bernardo do Campo 6
Thái Nguyên 6
Vienna 6
Boardman 5
Brno 5
Campinas 5
Caracas 5
Chennai 5
Columbus 5
Guarulhos 5
Houston 5
Kunming 5
Mexico City 5
Montevideo 5
Sofia 5
Baghdad 4
Bern 4
Bexley 4
Cape Town 4
Chengdu 4
Totale 3.792
Salva come PNG Salva come JPEG
Nome #
True double bifurcation lesions: new application of the self-expandable Axxess stent and review of literature with dedicated bifurcation devices 158
LA TRANSATTIVAZIONE Gβγ-DIPENDENTE DEL RECETTORE DELL’EGF E’ MEDIATA DAL RECETTORE DELL’UROTENSINA II 143
Effects of Successful Percutaneous Lower Extremity Revascularization on Cardiovascular Outcome in Patients with Peripheral Arterial Disease 116
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 115
Contemporary Evidence and Practice on Right Heart Catheterization in Patients with Acute or Chronic Heart Failure 111
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 111
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 110
Predictors of adherence to composite therapy after acute coronary syndromes 110
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 108
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 107
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 107
ATHERECTOMY AS ALTERNATIVE ENDOVASCULAR THERAPY FOR INFRAINGUINAL ARTERY DISEASE. 102
Quinacrine as a Novel Anti-Restenotic and Anti-Thrombotic Drug for Coronary Artery Interventions. 101
Low-dose quinacrine reduces vascular restenosis without affecting re-endothelialization 101
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 97
Very late bioresorbable scaffold thrombosis and reoccurrence of dissection two years later chronic total occlusion recanalization of the left anterior descending artery 97
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 96
Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis 96
Induction of mitogen activated protein kinases in response to pressure overload: a novel possible biomarker for uncontrolled human hypertension. 95
AngioJet rheolytic thrombectomy for acute superficial femoral artery stent or femoropopliteal by-pass thrombosis 95
Prevenzione della restenosi e della trombosi intrastent: ruolo del derivato acridinico quinacrina 94
Rotational atherectomy for the treatment of isolated femoral artery traumatic lesion: A case report 94
Vantaggi del trattamento endoprotesico degli aneurismi aortici in categorie ad alto rischio chirurgico 93
Ruolo del derivato acridinico Quinacrina nella prevenzione della restenosi e della trombosi intrastent. 92
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary intervention 92
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 91
Functionally complete coronary revascularisation in patients presenting with ST-elevation MI and multivessel coronary artery disease 91
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 90
L’Urotensina II svolge un ruolo protettivo nel rimodellamento post-ischemico e nella transizione verso lo scompenso cardiaco congestizio 90
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 90
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 90
L’ipertrofia miocardia da sovraccarico pressorio induce un notevole incremento dell’espressione di C-Flip, una proteina indispensabile per lo sviluppo embrionale del cuore 89
Ruolo dell’ UII nello sviluppo dell’ipertrofia cardiaca in vivo e nella transizione verso lo scompenso cardiaco congestizio 89
Quinacrine as a novel drug in the prevention of in-stent restenosis and thrombosis. 89
ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation. 89
Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel 89
Vantaggi del trattamento endoprotesico degli aneurismi aortici in categorie ad alto rischio chirurgico. 88
L’urotensina II svolge un ruolo protettivo nel rimodellamento post ischemico e nella transizione verso lo scompenso cardiaco congestizio 86
Gβγ-dependent transactivation of the epidermal growth factor receptor by the Urotensin-II receptor. 86
Histamine release, after peripheral ischemia, induce inteleukin 16 (II-16) expression and regulate collateral vessel development in mice. 85
Ruolo dell’UII nello sviluppo dell’ipertrofia cardiaca in vivo e nella transizione verso lo scompenso cardiaco congestizio. 84
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 83
Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel 83
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 81
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 80
Il ruolo dell’Urotensina II nel rimodellamento post-ischemico e nella transizione verso lo scompenso cardiaco congestizio 79
Ruolo dell’urotensina II (UII) nello sviluppo dell’ipertrofia cardiaca in vivo e nella transizione verso lo scompenso cardiaco congestizio 77
Double-kissing culotte technique for coronary bifurcation stenting 77
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI 76
FFR prediction model based on conventional quantitative coronary angiography and the amount of myocardium subtended by an intermediate coronary artery stenosis 75
Invasive Assessment of Coronary Microcirculation: A State-of-the-Art Review 73
Monocyte-platelets aggregates as cellular biomarker of endothelium-dependent coronary vasomotor dysfunction in patients with coronary artery disease. 73
Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. 72
Ruolo dell’Urotensina II nello sviluppo dell’ipertrofia cardiaca in vivo e nella transizione verso lo scompenso cardiaco congestizio 71
Artificial Intelligence as a Tool for Diagnosis of Cardiac Amyloidosis: A Systematic Review 69
La ridotta risposta ipertrofica da sovraccarico pressorio si associa a dilatazione ventricolare sinistra e ridotto reclutamento di cellule T CD4+ CD8+ in un modello murino di diabete mellito tipo II 69
Effetti dell’Urotensina II sulle proliferazione delle fibrocellule muscolari lisce 69
La ridotta risposta ipertrofica da sovraccarico pressorio si associa a dilatazione ventricolare sinistra e ridotto reclutamento di cellule T CD4+ CD8+ in un modello murino di diabete mellito tipo II 69
The role of fractional flow reserve to guide stent implantation. 68
Endovascular repair for isolated iliac artery aneurysms: case report and review of the current literature. 67
Uric acid plasma levels are associated with C-reactive protein concentrations and the extent of coronary artery lesions in patients with acute coronary syndromes 66
Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function. 66
The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion. 65
Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions: Results of the International Survey on Interventional Strategy. 65
Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. 63
Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI 62
Comparison of the Effect of Dual-Axis Rotational Coronary Angiography Versus Conventional Coronary Angiography on Frequency of Acute Kidney Injury, X-Ray Exposure Time, and Quantity of Contrast Medium Injected 62
Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts. 61
Macrophage migration inhibitory factor (MIF) is associated with degree of collateralization in patients with totally occluded coronary arteries 61
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 59
Pathophysiology and mechanisms of Acute Coronary Syndromes: atherothrombosis, immune-inflammation, and beyond 58
C-flip, A protein Required For Embryonic Heart Development, is markedly increased in pressure overload myocardial hypertrophy 58
Antiplatelet therapy in acute coronary syndromes. Lights and shadows of platelet function tests to guide the best therapeutic approach 57
Response to letter regarding article, "revascularization decisions in patients with stable angina and intermediate lesions: Results of the international survey on interventional strategy" 57
Impact of alpha- and Beta-adrenergic receptor blockers on fractional flow reserve and index of microvascular resistance. 56
Impact of negative lesion characteristics of chronic total occlusions on procedural outcome and strategy. 56
Stent implantation in the arteries of the lower limbs reduces cardiovascular risk in peripheral arterial disease. 55
SAFETY AND EFFICACY OF OUBACK CATHETER-ASSISTED SUBINTIMAL RECANALIZATION OF TOTAL CHRONIC ILIAC ARTERY OCCLUSION. 54
Quantitative angiography and optical coherence tomography for the functional assessment of nonobstructive coronary stenoses: comparison with fractional flow reserve. 54
[Ischemia with non-obstructive coronary artery disease: state-of-the-art review] 53
Impact of dual antiplatelet therapy duration on clinical outcome after coronary bifurcation stenting: results from the EuroBifurcation Club registry 53
How would I treat? The invited expert's opinion 53
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 52
RUOLO DEL DERIVATO ACRIDINICO QUINACRINA NELLA PREVENZIONE DELLA RESTENOSI E DELLA TROMBOSI INTRASTENT. 51
Prognostic value of fractional?flow?reserve: linking physiologic severity to clinical outcomes. 50
Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 50
Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment. 49
Periprocedural Myocardial Injury and Long-Term Clinical Outcome in Patients Undergoing Percutaneous Coronary Interventions of Coronary Chronic Total Occlusion 48
May FFR-guided PCI save lives?: Commentary on: “Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry” 47
ACEF vs PARIS score in Predicting Cardiovascular Events in Patients With Acute Coronary Syndrome: Insights From the START ANTIPLATELET Registry 46
Effects of urotensin II inhibition on smooth muscle cell proliferation and apoptosis 46
Transfemoral PTA of total subclavian occlusion anatomic definition prior stent implantation by Amicath rapid exchange catheter 46
In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR-OCT co-registration study 46
Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention. 45
Intracoronary EnalaPrilat to Reduce MICROvascular Damage During Percutaneous Coronary Intervention (ProMicro) study. 43
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 43
Potential additive effects of ticagrelor, ivabradine, and carvedilol on sinus node 38
Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry 38
Synergistic effect of thrombus aspiration and abciximab in primary percutaneous coronary intervention. 37
Response to letter to the editor regarding article "Macrophage migration inhibitory factor (MIF) is associated with degree of collateralization in patients with totally occluded coronary arteries" 35
Totale 7.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.909
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 20 4 8 10 2 19 13
2021/2022361 1 3 3 2 1 17 4 17 48 14 57 194
2022/2023511 80 32 23 14 58 36 7 31 65 124 24 17
2023/2024539 23 85 94 52 23 43 13 37 20 15 82 52
2024/20252.725 138 114 14 43 71 101 342 182 205 278 1.014 223
2025/20263.108 574 442 564 506 867 155 0 0 0 0 0 0
Totale 7.751